Approach to vasculitis: Clinical sciences

Last updated: May 06, 2025

Approach to vasculitis: Clinical sciences

Watch later

Watch later

Approach to hypertension: Clinical sciences
Chest X-ray interpretation: Clinical sciences
Acute mesenteric ischemia: Clinical sciences
Aortic dissection: Clinical sciences
Cardiac tamponade: Clinical sciences
Congestive heart failure: Clinical sciences
Hypovolemic shock: Clinical sciences
Infectious endocarditis: Clinical sciences
Mitral stenosis: Clinical sciences
Pericarditis: Clinical sciences
Peripheral arterial disease and ulcers: Clinical sciences
Right heart failure: Clinical sciences
Temporal arteritis: Clinical sciences
Valvular insufficiency (regurgitation): Clinical sciences
Approach to hyperthyroidism and thyrotoxicosis: Clinical sciences
Approach to hypothyroidism: Clinical sciences
Approach to hypoglycemia: Clinical sciences
Acute pancreatitis: Clinical sciences
Cushing syndrome and Cushing disease: Clinical sciences
Adrenal insufficiency: Clinical sciences
Diabetes mellitus (Type 1): Clinical sciences
Diabetes mellitus (Type 2): Clinical sciences
Hyperosmolar hyperglycemic state: Clinical sciences
Graves disease: Clinical Sciences
Diabetic ketoacidosis: Clinical sciences
Hashimoto thyroiditis: Clinical sciences
Hyperparathyroidism: Clinical sciences
Primary aldosteronism (hyperaldosteronism): Clinical sciences
Syndrome of inappropriate antidiuretic hormone secretion: Clinical sciences
Approach to periumbilical and lower abdominal pain: Clinical sciences
Acetaminophen (Paracetamol) toxicity: Clinical sciences
Appendicitis: Clinical sciences
Cholecystitis: Clinical sciences
Choledocholithiasis and cholangitis: Clinical sciences
Diverticulitis: Clinical sciences
Hepatic encephalopathy: Clinical sciences
Hepatitis A and E: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis C: Clinical sciences
Ileus: Clinical sciences
Irritable bowel syndrome: Clinical sciences
Large bowel obstruction: Clinical sciences
Peptic ulcer disease: Clinical sciences
Small bowel obstruction: Clinical sciences
Approach to bleeding disorders (coagulopathy): Clinical sciences
Approach to bleeding disorders (thrombocytopenia): Clinical sciences
Approach to bleeding disorders (platelet dysfunction): Clinical sciences
Approach to hypercoagulable disorders: Clinical sciences
Approach to leukemia: Clinical sciences
Iron deficiency anemia: Clinical sciences
Sickle cell disease: Clinical sciences
Vitamin B12 deficiency: Clinical sciences
Basal cell carcinoma: Clinical sciences
Burns: Clinical sciences
Lyme disease: Clinical sciences
Melanoma: Clinical sciences
Necrotizing soft tissue infections: Clinical sciences
Pressure-induced skin and soft tissue injury: Clinical sciences
Approach to lymphoma: Clinical sciences
Approach to hallucinogen, inhalant, and cannabis use, intoxication, and overdose: Clinical sciences
Approach to stimulant use, intoxication, and overdose: Clinical sciences
Approach to trauma and stressor-related disorders: Clinical sciences
Opioid intoxication and overdose: Clinical sciences
Bipolar I, bipolar II, and cyclothymic disorder: Clinical sciences
Opioid use disorder: Clinical sciences
Substance use disorder: Clinical sciences
Approach to a fever in the returned traveler: Clinical sciences
Approach to a postoperative fever: Clinical sciences
Approach to acid-base disorders: Clinical sciences
Approach to a fever: Clinical sciences
Approach to hypercalcemia: Clinical sciences
Approach to hyperkalemia: Clinical sciences
Approach to hyponatremia: Clinical sciences
Approach to metabolic alkalosis: Clinical sciences
Approach to nosocomial infections: Clinical sciences
Approach to metabolic acidosis: Clinical sciences
Approach to hypernatremia: Clinical sciences
Approach to respiratory acidosis: Clinical sciences
Approach to respiratory alkalosis: Clinical sciences
Infectious mononucleosis: Clinical sciences
Obesity and metabolic syndrome: Clinical sciences
Systemic lupus erythematosus: Clinical sciences
Tuberculosis (extrapulmonary and latent): Clinical sciences
Approach to unsteadiness, gait disturbance, or falls: Clinical sciences
Myasthenia gravis: Clinical sciences
Osteoarthritis: Clinical sciences
Septic arthritis: Clinical sciences
Spinal fractures: Clinical sciences
Rheumatoid arthritis: Clinical sciences
Spinal infection and abscess: Clinical sciences
Approach to aphasia: Clinical sciences
Approach to blunt traumatic cervical spine injuries: Clinical sciences
Approach to differentiating lesions (brainstem): Clinical sciences
Approach to differentiating lesions (cerebral cortical and subcortical structures): Clinical sciences
Approach to differentiating lesions (cerebellum): Clinical sciences
Approach to differentiating lesions (motor neuron): Clinical sciences
Approach to differentiating lesions (nerve root, plexus, and peripheral nerve): Clinical sciences
Approach to differentiating lesions (spinal cord): Clinical sciences
Approach to dysarthria or dysphagia: Clinical sciences
Approach to headache or facial pain: Clinical sciences
Approach to epilepsy: Clinical sciences
Approach to increased intracranial pressure: Clinical sciences
Approach to traumatic brain injury: Clinical sciences
Acute stroke (ischemic or hemorrhagic) or TIA: Clinical sciences
Delirium: Clinical sciences
Brain death: Clinical sciences
Diabetes insipidus: Clinical sciences
Guillain-Barré syndrome: Clinical sciences
Meningitis and brain abscess: Clinical sciences
Subarachnoid hemorrhage: Clinical sciences
Approach to lower limb edema: Clinical sciences
Approach to vasculitis: Clinical sciences
Deep vein thrombosis: Clinical sciences
Venous insufficiency and ulcers: Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Approach to vaginal discharge: Clinical sciences
Chlamydia trachomatis infection: Clinical sciences
Neisseria gonorrhoeae infection: Clinical sciences
Pelvic inflammatory disease: Clinical sciences
Approach to dyspnea: Clinical sciences
Approach to pneumoperitoneum and peritonitis (perforated viscus): Clinical sciences
Acute respiratory distress syndrome: Clinical sciences
Asthma in pregnancy: Clinical sciences
Airway obstruction: Clinical sciences
Atelectasis: Clinical sciences
Asthma: Clinical sciences
Community-acquired pneumonia: Clinical sciences
Empyema: Clinical sciences
Hospital-acquired and ventilator-associated pneumonia: Clinical sciences
Influenza: Clinical sciences
Pleural effusion: Clinical sciences
Pulmonary embolism: Clinical sciences
Pneumothorax: Clinical sciences
Upper respiratory tract infections: Clinical sciences
Tuberculosis (pulmonary): Clinical sciences
Approach to acute kidney injury: Clinical sciences
Catheter-associated urinary tract infection: Clinical sciences
Intrinsic acute kidney injury (glomerular causes): Clinical sciences
Chronic kidney disease: Clinical sciences
Intrinsic acute kidney injury (non-glomerular causes): Clinical sciences
Lower urinary tract infection: Clinical sciences
Postrenal acute kidney injury: Clinical sciences
Pyelonephritis: Clinical sciences
Prerenal acute kidney injury: Clinical sciences
Asthma: Information for patients and families (The Primary School)
Food allergies and EpiPens: Information for patients and families (The Primary School)
Empathetic listening for clinicians
Shared decision-making
Implicit bias
The do's and don'ts of patient care
Cardiovascular disease screening: Clinical sciences
Essential hypertension: Clinical sciences
Approach to a murmur (pediatrics): Clinical sciences
Carotid artery stenosis screening: Clinical sciences
Acute rheumatic fever and rheumatic heart disease: Clinical sciences
Randomized control trial
Clinical trials
Study designs
Bias in performing clinical studies
Problem-based learning
Sample size
Information bias
Selection bias
Case-control study
Cohort study
Hypothesis testing: One-tailed and two-tailed tests
Correlation
Paired t-test
Types of data
Bias in interpreting results of clinical studies
Two-sample t-test
The role of the kidney in acid-base balance
Anatomy of the glossopharyngeal nerve (CN IX)
Anticoagulants: Warfarin
Class I antiarrhythmics: Sodium channel blockers
Hepatitis A and Hepatitis E virus
Class IV antiarrhythmics: Calcium channel blockers and others
Anatomy clinical correlates: Oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Anatomy of the facial nerve (CN VII)
Anatomy of the vestibulocochlear nerve (CN VIII)
Anatomy clinical correlates: Glossopharyngeal (CN IX), vagus (X), spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Anatomy clinical correlates: Facial (CN VII) and vestibulocochlear (CN VIII) nerves
Anatomy of the trigeminal nerve (CN V)
Anatomy of the spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Anatomy of the vagus nerve (CN X)
Definitions of acids and bases
Anatomy clinical correlates: Trigeminal nerve (CN V)
Kidney stones: Pathology review
Meningitis
Cellulitis and erysipelas: Clinical sciences
Sepsis: Clinical sciences
Bacterial vaginosis: Clinical sciences
Aspiration pneumonia and pneumonitis: Clinical sciences
Clostridioides difficile infection: Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Vasculitis refers to inflammation of blood vessels, which can result in vessel wall damage, bleeding, and ischemia of affected organs. Based on the size of the affected blood vessels, large-vessel vasculitis affects vessels like the aorta and its branches; medium-vessel vasculitis primarily affects major visceral arteries like renal and mesenteric arteries; small-vessel vasculitis mostly affects arterioles and capillaries; and variable-vessel vasculitis can affect vessels of any size.

Now, if your patient presents with a chief concern suggesting vasculitis, first perform an ABCDE assessment to determine if they are unstable or stable. If unstable, stabilize their airway, breathing, and circulation. Obtain IV access and put your patient on continuous vital sign monitoring including heart rate, blood pressure, and pulse oximetry; as well as cardiac telemetry. If needed, provide supplemental oxygen.

Now here’s a clinical pearl to keep in mind! Vasculitides that commonly present as unstable include ANCA-associated small-vessel vasculitis, which can cause diffuse alveolar hemorrhage; and anti-glomerular basement membrane or anti-GBM disease, which can cause damage to the glomerular basement membrane. Together, these conditions can result in pulmonary-renal syndrome, which can lead to respiratory and renal failure!

Now, let’s go back to the ABCDE assessment and discuss stable patients. In this case, obtain a focused history and physical examination; and order labs, including CBC, CMP, ESR, CRP, and urinalysis. Your patient will typically report constitutional symptoms, including fever, fatigue, anorexia, and weight loss; as well as epistaxis, limb claudication, and Raynaud phenomenon.

Ask about symptoms that could indicate involvement of specific organ systems. These patients may experience wheezing or hemoptysis; rash or skin discoloration; sensory disturbances like vision loss or limb weakness; or discolored urine or anuria. The physical exam may reveal an elevated temperature, as well as vascular findings like decreased, asymmetric pulses with vessel tenderness to palpation.

You may notice organ-specific findings like nasal crusting or abnormal lung sounds; palpable purpura or skin ulceration; sensory deficits, such as numbness; or motor deficits like foot drop.

As far as labs go, the CBC usually reveals leukocytosis with neutrophilic predominance, thrombocytosis, and low hemoglobin and hematocrit. The CMP might show elevated BUN and creatinine; the ESR and CRP are generally elevated, and the urinalysis may reveal hematuria or proteinuria.

With these findings, consider vasculitis, and order labs to confirm the diagnosis and determine the underlying cause. Start by ordering the antineutrophil cytoplasmic antibodies, or ANCA, subtypes MPO-ANCA and PR3-ANCA. Next, order antinuclear antibody or ANA and anti-glomerular basement membrane, or anti-GBM antibody, as well as serum cryoglobulins and rheumatoid factor, or RF. Also check the complement levels, serum immunoglobulins, and serologies for hepatitis B, hepatitis C, and HIV.

Now, let’s start with large-vessel vasculitis, which includes Takayasu arteritis and giant cell arteritis. Takayasu arteritis is more common in biological females under the age of 50. Patients usually report claudication, or pain in the limbs during movement. The physical exam will reveal unequal blood pressure between arms and diminished pulses in the extremities. Arterial bruits may also be present.

With these findings, consider Takayasu arteritis, and order MR angiography of the arterial tree. If CT or MR angiography reveals luminal narrowing or vascular wall thickening of large vessels such as the aorta or its primary branches, this confirms a diagnosis of Takayasu arteritis.

On the flip side, giant cell arteritis is more common in patients over 50 years of age, and is often associated with polymyalgia rheumatica. These individuals typically report unilateral headaches and jaw claudication while chewing. Some patients may also report vision loss. The physical exam often reveals an enlarged, tender, and nodular temporal artery.

At this point, consider giant cell arteritis. To confirm, obtain either a temporal artery biopsy or an ultrasound of the temporal artery with Doppler. If the biopsy reveals transmural inflammatory infiltration with giant cells, or the ultrasound shows a circumferential thickening of the vascular wall around the lumen, or the classic halo sign, diagnose giant cell arteritis.

Alright, switching gears to medium-vessel vasculitis, which includes polyarteritis nodosa and thromboangiitis obliterans. Individuals with polyarteritis nodosa typically report abdominal and extremity pain, and weakness. The physical exam reveals livedo reticularis, characterized by lacy, mottled skin discoloration often in combination with skin ulcers and nodules. Finally, you might notice concurrent sensorimotor deficits in various locations, such as sciatic and radial neuropathy, which is often referred to as mononeuritis multiplex.

Labs may reveal hematuria with no red blood cell casts, and in some cases, positive hepatitis B serology. With these findings, consider polyarteritis nodosa, and order a renal or mesenteric angiography. If it shows microaneurysms and focal vessel narrowing and occlusion, diagnose polyarteritis nodosa.

On the other hand, patients with thromboangiitis obliterans are almost exclusively younger than 50 years old, with heavy tobacco use. The physical exam typically reveals digital ulcers, and sometimes gangrene.

With these findings, consider thromboangiitis obliterans and obtain an ankle-brachial index or wrist-brachial index of the involved extremities. You may also need an angiogram of the extremities. If the ankle-brachial or wrist-brachial index is abnormal, or the angiography shows segmental arterial occlusions with collateral vessel formation which gives a classic ‘corkscrew’ appearance, diagnose thromboangiitis obliterans!

Sources

  1. "2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. " Arthritis Rheumatol (2021;73(8):1366-1383. )
  2. "2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis. " Arthritis Care Res (Hoboken) (2021;73(8):1071-1087. )
  3. "2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa. " Arthritis Care Res (Hoboken) (2021;73(8):1061-1070. )
  4. "IgA vasculitis (Henoch-Shönlein purpura) in adults: Diagnostic and therapeutic aspects. " Autoimmun Rev. (2015;14(7):579-585. )
  5. "Diagnosis and classification of Goodpasture's disease (anti-GBM). " J Autoimmun (2014;48-49:108-112. )
  6. "Medium- and Large-Vessel Vasculitis." Circulation. (2021;143(3):267-282.)
  7. "ANCA associated vasculitis. " Eur J Intern Med. (2020;74:18-28. )
  8. "Diagnostic approach to patients with suspected vasculitis. " Postgrad Med J. (2006;82(970):483-488. )
  9. "ANCA associated vasculitis (AAV): a review for internists. " Postgrad Med. (2023;135(sup1):3-13. )